These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 18618095)

  • 1. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps.
    Groenewoud MJ; Dekker JM; Fritsche A; Reiling E; Nijpels G; Heine RJ; Maassen JA; Machicao F; Schäfer SA; Häring HU; 't Hart LM; van Haeften TW
    Diabetologia; 2008 Sep; 51(9):1659-63. PubMed ID: 18618095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
    Wu Y; Li H; Loos RJ; Yu Z; Ye X; Chen L; Pan A; Hu FB; Lin X
    Diabetes; 2008 Oct; 57(10):2834-42. PubMed ID: 18633108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function.
    Pascoe L; Tura A; Patel SK; Ibrahim IM; Ferrannini E; Zeggini E; Weedon MN; Mari A; Hattersley AT; McCarthy MI; Frayling TM; Walker M; ;
    Diabetes; 2007 Dec; 56(12):3101-4. PubMed ID: 17804762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined risk allele score of eight type 2 diabetes genes is associated with reduced first-phase glucose-stimulated insulin secretion during hyperglycemic clamps.
    't Hart LM; Simonis-Bik AM; Nijpels G; van Haeften TW; Schäfer SA; Houwing-Duistermaat JJ; Boomsma DI; Groenewoud MJ; Reiling E; van Hove EC; Diamant M; Kramer MH; Heine RJ; Maassen JA; Kirchhoff K; Machicao F; Häring HU; Slagboom PE; Willemsen G; Eekhoff EM; de Geus EJ; Dekker JM; Fritsche A
    Diabetes; 2010 Jan; 59(1):287-92. PubMed ID: 19808892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion.
    Kirchhoff K; Machicao F; Haupt A; Schäfer SA; Tschritter O; Staiger H; Stefan N; Häring HU; Fritsche A
    Diabetologia; 2008 Apr; 51(4):597-601. PubMed ID: 18264689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians.
    Rong R; Hanson RL; Ortiz D; Wiedrich C; Kobes S; Knowler WC; Bogardus C; Baier LJ
    Diabetes; 2009 Feb; 58(2):478-88. PubMed ID: 19008344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between insulin secretion, insulin sensitivity and type 2 diabetes susceptibility variants identified in genome-wide association studies.
    Ruchat SM; Elks CE; Loos RJ; Vohl MC; Weisnagel SJ; Rankinen T; Bouchard C; Pérusse L
    Acta Diabetol; 2009 Sep; 46(3):217-26. PubMed ID: 19082521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population.
    Hu C; Zhang R; Wang C; Wang J; Ma X; Lu J; Qin W; Hou X; Wang C; Bao Y; Xiang K; Jia W
    PLoS One; 2009 Oct; 4(10):e7643. PubMed ID: 19862325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
    Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
    J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians.
    Chauhan G; Spurgeon CJ; Tabassum R; Bhaskar S; Kulkarni SR; Mahajan A; Chavali S; Kumar MV; Prakash S; Dwivedi OP; Ghosh S; Yajnik CS; Tandon N; Bharadwaj D; Chandak GR
    Diabetes; 2010 Aug; 59(8):2068-74. PubMed ID: 20424228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians.
    Ng MC; Park KS; Oh B; Tam CH; Cho YM; Shin HD; Lam VK; Ma RC; So WY; Cho YS; Kim HL; Lee HK; Chan JC; Cho NH
    Diabetes; 2008 Aug; 57(8):2226-33. PubMed ID: 18469204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.
    van Hoek M; Langendonk JG; de Rooij SR; Sijbrands EJ; Roseboom TJ
    Diabetes; 2009 Jun; 58(6):1440-4. PubMed ID: 19258437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies.
    Grarup N; Rose CS; Andersson EA; Andersen G; Nielsen AL; Albrechtsen A; Clausen JO; Rasmussen SS; Jørgensen T; Sandbaek A; Lauritzen T; Schmitz O; Hansen T; Pedersen O
    Diabetes; 2007 Dec; 56(12):3105-11. PubMed ID: 17827400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies.
    Herder C; Rathmann W; Strassburger K; Finner H; Grallert H; Huth C; Meisinger C; Gieger C; Martin S; Giani G; Scherbaum WA; Wichmann HE; Illig T
    Horm Metab Res; 2008 Oct; 40(10):722-6. PubMed ID: 18597214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
    Moore AF; Jablonski KA; McAteer JB; Saxena R; Pollin TI; Franks PW; Hanson RL; Shuldiner AR; Knowler WC; Altshuler D; Florez JC;
    Diabetes; 2008 Sep; 57(9):2503-10. PubMed ID: 18544707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6,733 non-diabetic Finnish men.
    Vangipurapu J; Stančáková A; Pihlajamäki J; Kuulasmaa TM; Kuulasmaa T; Paananen J; Kuusisto J; Ferrannini E; Laakso M
    Diabetologia; 2011 Mar; 54(3):563-71. PubMed ID: 21153532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of CDKAL1 rs7756992 and IGF2BP2 rs4402960 polymorphisms in type 2 diabetes, diabetic complications, obesity risk and hypertension in the Tunisian population.
    Lasram K; Ben Halim N; Benrahma H; Mediene-Benchekor S; Arfa I; Hsouna S; Kefi R; Jamoussi H; Ben Ammar S; Bahri S; Abid A; Benhamamouch S; Barakat A; Abdelhak S
    J Diabetes; 2015 Jan; 7(1):102-13. PubMed ID: 24636221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.
    Stancáková A; Pihlajamäki J; Kuusisto J; Stefan N; Fritsche A; Häring H; Andreozzi F; Succurro E; Sesti G; Boesgaard TW; Hansen T; Pedersen O; Jansson PA; Hammarstedt A; Smith U; Laakso M;
    J Clin Endocrinol Metab; 2008 May; 93(5):1924-30. PubMed ID: 18285412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening.
    Tabara Y; Osawa H; Kawamoto R; Onuma H; Shimizu I; Miki T; Kohara K; Makino H
    Diabetes; 2009 Feb; 58(2):493-8. PubMed ID: 19033397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan.
    Horikawa Y; Miyake K; Yasuda K; Enya M; Hirota Y; Yamagata K; Hinokio Y; Oka Y; Iwasaki N; Iwamoto Y; Yamada Y; Seino Y; Maegawa H; Kashiwagi A; Yamamoto K; Tokunaga K; Takeda J; Kasuga M
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3136-41. PubMed ID: 18477659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.